Abstract:Objective: This study explores the impact of pyroptosis-related genes (PRG) on the prognosis of liver cancer (LC). Methods: 421 samples (371 tumor samples and 50 normal samples) from the Cancer Genome Atlas (TCGA) were included in this study. GSE14520 dataset (data of RNA expression and relevant clinicopathological features), GSE125449 dataset (single-cell data in LC) and HCCDB18 dataset (validation on the reliability of the model) were downloaded as appropriate. Download the PRG and its corresponding pathway information from the gene set enrichment analysis (GSEA) website. The consensus clustering was performed by ConsensusClusterPlus package. Differentially expressed genes (DEGs) were identified using limma package, and prognostic features were constructed using un/multivariate and Lasso Cox regression. Pathway enrichment analysis was conducted by ssGSEA method. Receiver Operating Characteristic and the survival analysis were conducted by timeROC and Survminer packages. The Seurat package was used for single-cell RNA sequencing (scRNA-seq) analysis. For cellular validation, following the quantification on the key genes via reverse-transcription quantitative PCR, the Transwell and scratch assays were applied to evaluate the in-vitro invasion and migration of LC cells Huh-7. Results: 12 prognosis-related genes were identified to be related to the progression of LC. Three subtypes including C1, C2 and C3 were categorized using the 12 prognosis-related genes and PRGs significantly related to the prognosis of LC patients. The worst and best prognosis was seen in C3 subtype and C2 subtype, respectively. Hallmark pathway enrichment analysis has shown the concurrent immunoactivation and immune escape in C3 subtype. A RiskScore model was constructed using 8 key genes (KPNA2, UCK2, FTCD, CBX2, RAB32, HMMR, S100A9 and ANXA10) from the DEGs of three subtypes. The RiskScore system as an independent prognostic factor dividing the patients into high and low risk groups, and patients of the high-risk group had poor prognosis in both test set and validation set. A nomogram model combining the risk score had the extreme higher benefit. Further, 6 subclusters were identified from scRNA-seq analysis, where the highest PYROPTOSIS score was seen in Monocytic-Macrophages. The quantification on the key genes has suggested the high expressions of KPNA2, UCK2, CBX2, RAB32, HMMR and S100A9 and the low expressions of FTCD and ANXA10 in LC cells Huh-7. Particularly, UCK2 knockdown evidently diminished the number of invaded and migrated LC cells in vitro. Conclusion: The risk model associated with pyproptosis is crucial for the tumor immunity of LC and may serve as a prognostic indicator for patients suffering from LC. Our findings will offer new perspectives for immunotherapies targeting LC.

Role of LRG1 in the Cell Proliferation, Migration, and Prognosis of Pancreatic Cancer

LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling

The role of leucine-rich alpha-2-glycoprotein-1 in proliferation, migration, and invasion of tumors

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.

LRG1 Modulates Epithelial-Mesenchymal Transition and Angiogenesis in Colorectal Cancer Via HIF-1α Activation

LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition

LRG1 Promotes Proliferation and Inhibits Apoptosis in Colorectal Cancer Cells Via RUNX1 Activation.

LRG1 is an Independent Prognostic Factor for Endometrial Carcinoma

LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells

LRG1 Is Involved in the Progression of Ovarian Cancer via Modulating FAK/AKT Signaling Pathway

Progress of a brand new target LRG1 for tumor angiogenesis

Leucine-rich Alpha-2-glycoprotein-1, Relevant with Microvessel Density, is an Independent Survival Prognostic Factor for Stage III Colorectal Cancer Patients: a Retrospective Analysis

Low Level of Low-Density Lipoprotein Receptor-Related Protein 1 Predicts an Unfavorable Prognosis of Hepatocellular Carcinoma after Curative Resection.

Overexpression of Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) is Associated with Worsened Prognosis and Decreased Cancer Immunity in Clear-Cell Renal Cell Carcinoma.

A Role for LRIG1 in the Regulation of Malignant Glioma Aggressiveness.

Positive feedback regulation of lncRNA TPT1‐AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer

Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene Via Maintaining Mitochondrial Function in Pancreatic Cancer

LDL Receptor Related Protein 2 to Promote Colorectal Cancer Metastasis Via Enhancing GSK3β/β-catenin Signaling.

Clinicopathological and Prognostic Significance of Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1 (LRIG1) in Malignant Tumors: A Meta-Analysis

Pyroptosis-related genes features on prediction of the prognosis in liver cancer: An integrated analysis of bulk and single-cell RNA sequencing

The Lncrna ENSG00000254041.1 Promotes Cell Invasiveness and Associates with Poor Prognosis of Pancreatic Ductal Adenocarcinoma.